Medical Xpress news

Medical Xpress / Small-molecule antiviral drug targets ACE2 receptor to block coronaviruses from entering cells

The ongoing evolution of SARS-CoV-2, particularly the rapid emergence of the omicron variant and its sublineages, has weakened the effectiveness of existing vaccines and antiviral drugs, underscoring the potential risk of ...

Jun 25, 2026
Medical Xpress / Special protein in the brain's cleansing system may contribute to loss of brain function in Alzheimer's

Alzheimer's disease is a progressive and permanent loss of nerve cells in the brain. The breakdown causes memory loss, functional impairment and personality changes. In a new study published in Nature Aging, researchers found ...

Jun 25, 2026
Medical Xpress / Identifying immune pathways driving aggressive brain cancers

A new study has uncovered a key mechanism that helps one of the deadliest brain cancers evade the immune system, according to the study published in The Journal of Clinical Investigation.

Jun 25, 2026
Medical Xpress / Nanotech platform combining paclitaxel with siRNA boosts immune response against lung cancer

Researchers at the University of Arizona R. Ken Coit College of Pharmacy have developed a new strategy that helps the immune system recognize and attack lung cancer tumors more effectively. By packaging a chemotherapy drug ...

Jun 25, 2026
Medical Xpress / New mechanism found for neuronal death in Alzheimer's and frontotemporal dementia

Markers of a new mechanism for cell death, called karyoptosis, have been found in the brains of patients with Alzheimer's disease and frontotemporal dementia (FTD).

Jun 25, 2026
Medical Xpress / Hidden thymus step may prime cancer-killing T cells earlier than expected

Researchers at Mayo Clinic have uncovered a previously hidden step in how the immune system prepares to fight cancer, a discovery that could help scientists develop more effective and longer-lasting cancer immunotherapies.

Jun 25, 2026
Medical Xpress / Clinical study of drug-resistant tuberculosis changes global medical practice

A clinical study that began in a research unit in Gqeberha (PE), Eastern Cape, has transformed global treatment of drug-resistant tuberculosis.

Jun 25, 2026
Medical Xpress / New oral heart failure drug appears to be safe and well tolerated in 58-patient early clinical trial

An early clinical study shows that a new oral drug is safe and well tolerated in patients with chronic heart failure. The study, led by researchers at Karolinska Institutet, has been published in The Lancet.

Jun 25, 2026
Medical Xpress / Armed conflict is linked to increased measles cases globally

Countries experiencing armed conflict tend to report more measles cases, and the elevated risk persists even a year after the fighting, according to new research published in PLOS Medicine. The study links armed conflict ...

Jun 25, 2026
Medical Xpress / Stress-linked gut viruses may help tumors evade the immune system

Chronic psychological stress can help tumors evade immune attack through a chain of molecular events involving gut bacteria and viruses within those bacteria, according to a study led by Weill Cornell Medicine investigators. ...

Jun 25, 2026
Medical Xpress / Eliminating cancer cells that survive KRAS inhibition: A potential way to prevent relapse

Our cells rely on tightly regulated signaling pathways to control when they grow, divide and survive. When these regulatory systems are disrupted, cells can acquire the ability to grow uncontrollably and become cancerous. ...

Jun 25, 2026
Medical Xpress / Molecular machinery in cardiac mitochondria reacts to metabolic stress in unexpected way

In a recent study published in Nature Communications, researchers at Karolinska Institutet report that the molecular machinery responsible for cellular energy conversion is more interconnected than previously understood, ...

Jun 25, 2026